PT3133072T - Novos compostos derivados de 6,7-dihidro-3-oxazolo[3,4- a]pirazina-5,8-diona - Google Patents
Novos compostos derivados de 6,7-dihidro-3-oxazolo[3,4- a]pirazina-5,8-dionaInfo
- Publication number
- PT3133072T PT3133072T PT15752140T PT15752140T PT3133072T PT 3133072 T PT3133072 T PT 3133072T PT 15752140 T PT15752140 T PT 15752140T PT 15752140 T PT15752140 T PT 15752140T PT 3133072 T PT3133072 T PT 3133072T
- Authority
- PT
- Portugal
- Prior art keywords
- oxazolo
- pyrazine
- dihydro
- novel
- derivative compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461943825P | 2014-02-24 | 2014-02-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3133072T true PT3133072T (pt) | 2019-07-26 |
Family
ID=53877456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT15752140T PT3133072T (pt) | 2014-02-24 | 2015-02-24 | Novos compostos derivados de 6,7-dihidro-3-oxazolo[3,4- a]pirazina-5,8-diona |
Country Status (19)
Country | Link |
---|---|
US (1) | US9359378B2 (pt) |
EP (1) | EP3133072B1 (pt) |
JP (1) | JP6636463B2 (pt) |
KR (1) | KR102408431B1 (pt) |
AR (1) | AR099523A1 (pt) |
AU (1) | AU2015221431B2 (pt) |
BR (1) | BR112016019609B1 (pt) |
CA (1) | CA2940225C (pt) |
CL (1) | CL2016002125A1 (pt) |
ES (1) | ES2734063T3 (pt) |
HU (1) | HUE044993T2 (pt) |
IL (1) | IL247330B (pt) |
MX (1) | MX369840B (pt) |
PL (1) | PL3133072T3 (pt) |
PT (1) | PT3133072T (pt) |
TR (1) | TR201910896T4 (pt) |
UY (1) | UY36010A (pt) |
WO (1) | WO2015123748A1 (pt) |
ZA (1) | ZA201606522B (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022540866A (ja) * | 2019-07-15 | 2022-09-20 | バイオラブ・サヌス・ファーマセウティカ・エルティーディーエー. | 3-(ベンゾ[d][1,3]ジオキサゾール-5-イル)-7-(1-ヒドロキシプロパン-2-イル)-1-(1H-インドール-3-イル)-6,7-ジヒドロ-3H-オキサゾール[3,4-a]ピラジン-5,8-ジオン化合物の立体異性体およびその抗腫瘍剤およびホスホジエステラーゼ酵素阻害剤としての使用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60226970D1 (de) * | 2001-06-05 | 2008-07-17 | Lilly Icos Llc | Pyrazinoä1',2':1,6ü-pyridoä3,4-bü indole-1,4-dionderivate |
AR045950A1 (es) * | 2003-10-09 | 2005-11-16 | Speedel Experimenta Ag | Compuestos derivados de piperazina, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos. |
AR073522A1 (es) * | 2008-09-30 | 2010-11-10 | Biolab Sanus Farmaceutica Ltda | Compuestos derivados de 2-(3-metilenodioxi) - benzoil indol |
BRPI0903803B1 (pt) * | 2009-09-30 | 2019-07-09 | Biolab Sanus Farmacêutica Ltda. | Composto, processo de preparação, composição farmacêutica e uso dos compostos |
UY33535A (es) * | 2010-08-13 | 2011-12-01 | Biolab Sanus Farmaceutuca Limitada | Derivados de 6,7-dihidro-3h-oxazolo[3,4]pirazin-5,8-diona |
-
2015
- 2015-02-23 AR ARP150100529A patent/AR099523A1/es active IP Right Grant
- 2015-02-24 KR KR1020167026361A patent/KR102408431B1/ko active IP Right Grant
- 2015-02-24 AU AU2015221431A patent/AU2015221431B2/en active Active
- 2015-02-24 US US14/630,410 patent/US9359378B2/en active Active
- 2015-02-24 UY UY0001036010A patent/UY36010A/es active IP Right Grant
- 2015-02-24 JP JP2016570147A patent/JP6636463B2/ja active Active
- 2015-02-24 EP EP15752140.2A patent/EP3133072B1/en active Active
- 2015-02-24 MX MX2016010912A patent/MX369840B/es active IP Right Grant
- 2015-02-24 ES ES15752140T patent/ES2734063T3/es active Active
- 2015-02-24 WO PCT/BR2015/000023 patent/WO2015123748A1/pt active Application Filing
- 2015-02-24 PT PT15752140T patent/PT3133072T/pt unknown
- 2015-02-24 CA CA2940225A patent/CA2940225C/en active Active
- 2015-02-24 PL PL15752140T patent/PL3133072T3/pl unknown
- 2015-02-24 TR TR2019/10896T patent/TR201910896T4/tr unknown
- 2015-02-24 HU HUE15752140 patent/HUE044993T2/hu unknown
- 2015-02-24 BR BR112016019609-0A patent/BR112016019609B1/pt active IP Right Grant
-
2016
- 2016-08-17 IL IL247330A patent/IL247330B/en active IP Right Grant
- 2016-08-23 CL CL2016002125A patent/CL2016002125A1/es unknown
- 2016-09-21 ZA ZA2016/06522A patent/ZA201606522B/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR112016019609A2 (pt) | 2017-08-22 |
AU2015221431A1 (en) | 2016-09-29 |
US9359378B2 (en) | 2016-06-07 |
CL2016002125A1 (es) | 2016-12-30 |
KR20160116028A (ko) | 2016-10-06 |
UY36010A (es) | 2015-09-30 |
CA2940225A1 (en) | 2015-08-27 |
HUE044993T2 (hu) | 2019-11-28 |
EP3133072A1 (en) | 2017-02-22 |
AU2015221431B2 (en) | 2018-04-19 |
ES2734063T3 (es) | 2019-12-04 |
AU2015221431A8 (en) | 2016-11-24 |
MX2016010912A (es) | 2016-11-30 |
CA2940225C (en) | 2021-12-28 |
AR099523A1 (es) | 2016-07-27 |
EP3133072A4 (en) | 2017-08-09 |
IL247330A0 (en) | 2016-09-29 |
JP2017506263A (ja) | 2017-03-02 |
EP3133072B1 (en) | 2019-05-01 |
TR201910896T4 (tr) | 2019-08-21 |
IL247330B (en) | 2020-10-29 |
ZA201606522B (en) | 2018-04-25 |
WO2015123748A1 (pt) | 2015-08-27 |
US20150239903A1 (en) | 2015-08-27 |
BR112016019609B1 (pt) | 2022-06-14 |
KR102408431B1 (ko) | 2022-06-13 |
PL3133072T3 (pl) | 2019-10-31 |
JP6636463B2 (ja) | 2020-01-29 |
MX369840B (es) | 2019-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201616511D0 (en) | Novel compounds | |
GB201614134D0 (en) | Novel compounds | |
GB201604647D0 (en) | Novel compounds | |
GB201604638D0 (en) | Novel compounds | |
EP3286169A4 (en) | Novel compounds | |
GB201610147D0 (en) | Novel compounds | |
GB201602854D0 (en) | Novel compounds | |
GB201603779D0 (en) | Novel compounds | |
EP3177285A4 (en) | [5,6]-fused bicyclic antidiabetic compounds | |
EP3177614A4 (en) | [7,6]-fused bicyclic antidiabetic compounds | |
EP3148975A4 (en) | Novel compounds | |
ZA201607765B (en) | Novel macrocyclic compounds | |
GB201613163D0 (en) | Novel compounds | |
EP3148985A4 (en) | Novel compounds | |
EP3148987A4 (en) | Novel compounds | |
HK1221463A1 (zh) | 可用作 抑制劑的新型化合物 | |
HK1256825A1 (zh) | 取代的5,6-二氫-6-苯基苯並[f]異喹啉-2-胺化合物的固體形式 | |
GB201618346D0 (en) | Novel compounds | |
GB201619514D0 (en) | Novel compounds | |
GB201601301D0 (en) | Novel compounds | |
ZA201606522B (en) | Novel 6,7-dihydro-3h-oxazolo[3,4-a]pyrazine-5,8-dione derivative compounds | |
GB201615191D0 (en) | Novel compounds | |
EP3555115A4 (en) | NOVEL COMPOUNDS AS ANTI-MYCOBACTERIA | |
AU2016905229A0 (en) | Novel compounds as anti-mycobacterials | |
GB201616907D0 (en) | Novel Compounds |